Iskoobka Gudaha ee Kharashka Daaweynta Kansarka Naasaha ee Hindiya - Muujin Waa in La Akhriyaa!

Kansarka naasaha ayaa 31% ka ah dhammaan kansarrada laga helo dumarka Hindiya, taasoo ka dhigaysa nooca ugu horreeya ee kansarka. Cudurkan halista ah waa in lagu daweeyaa marxaladda hore si loo helo natiijooyinka ugu wanaagsan. Boggeena wuxuu jebiyaa kansarka naasaha t..

Abemaciclib, aromatase inhibitor, Eli Lilly iyo Shirkadda, daaweynta endocrine, tamoxin, Verzenio

Abemaciclib oo leh daawaynta endocrine waxa ansixisay FDA gudaha HER 2 kansarka naasaha ee togan

Maarso 2023: Abemaciclib (Verzenio, Eli Lilly iyo Company) iyo daawaynta endocrine (tamoxifen ama aromatase inhibitor) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka (FDA) ee daawaynta kaabayaal ee bukaanka qaangaarka ah ee leh ..

Shiinaha, Enhertu, HER 2 togan

Enhertu waxaa Shiinaha looga oggolaaday bukaannada qaba kansarka naasaha ee HER2-positive metastatic

Feb 2023: Enhertu (trastuzumab deruxtecan) from AstraZeneca and Daiichi Sankyo has been approved as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received ..

Hamsa, Xamsa Nandini, Mirchi, Filimka Mirchi

Jilaaga Xamsa Nandini Oo Bixiyay Warbixin Hal Sano Kadib Daawaynta Kansarka Naasaha

Feb 2023: Hamsa Nandini, oo laga helay Fasalka III Kansarka Invasive Carcinoma (kanarka naaska) sanadka 2021, ayaa cusboonaysiisay taageerayaasheeda Instagram xaaladeeda caafimaad. Aktaradan oo kasoo muuqatay aflaan Telugu ah sida Mirchi iyo Lege.

Gilead Sciences, sacituzumab govitecan-hziy, Trodelvy, TROPiCS-02

Sacituzumab govitecan-hziy waxa u ansixisay FDA ee kansarka naasaha ee HR

Feb 2023: Maamulka Cuntada iyo Dawooyinka (FDA) waxa ay ansixisay sacituzumab govitecan-hziy (Trodelvy, Gilead Sciences, Inc.) ee loogu talagalay dadka qaba hormoonka soo-qabtayaasha (HR) -positive, HER2-negative (IHC 0, IHC 1+, ama IHC 2+/ISH-) kansar naasaha

dhalaalid, Orserdu, Daaweynta Stemline

Elacestrant waxa u ansixisay FDA ER-positive, HER2-negative, ESR1-mutated horumarsan ama kansarka naasaha.

Bishii Febraayo 2023, Maamulka Cuntada iyo Dawooyinka (FDA) waxay ansixiyeen elacestrant (Orserdu, Stemline Therapeutics, Inc.) dumarka ama ragga ka weyn 50 ee uu ku dhacay kansarka naasaha oo horumaray ama metastatic ah oo ER-positive ah, HER2-negative, iyo h..

Daichi Sankyo, Enhertu, fam-trastuzumab deruxtecan-nxki

Fam-trastuzumab deruxtecan-nxki waxay FDA u ogolaatay kansarka naasaha

Abriil 2022: Bukaannada qaan-gaarka ah ee qaba kansarka naasaha ee HER2-positive ee aan la sixi karin ama metastatic kuwaas oo helay nidaam ka-hortagga-HER2-ku-saleysan ee hore ee goobta metastatic, ama goobta neoadjuvant ama adjuvant oo ay soo baxeen.

AstraZeneca Pharmaceuticals, BRCA, gBRCAm, Lynparza, olaparib, OlympiA

Olaparib waxaa loo oggolaaday daawaynta adjuvant ee halista sare leh ee hore ee kansarka naasaha

Maarso 2022: Maamulka Cuntada iyo Dawooyinka ayaa ansixiyay olaparib (Lynparza, AstraZeneca Pharmaceuticals, LP) ee daawaynta adjuvant ee bukaanka qaangaarka ah ee leh jeermiska tirtira ama looga shakisan yahay BRCA-mutated (gBRCAm) h..

Abemaciclib, Cilmiga, Dako Omnis, Eli Lilly iyo Shirkadda, daaweynta endocrine, tamoxin, Verzenio

Abemaciclib waxaa ansixiyay FDA oo leh daawaynta endocrine ee kansarka naasaha ee hore

Oktoobar 2021: Maamulka Cuntada iyo Dawooyinka ayaa ansixiyay abemaciclib (Verzenio, Eli Lilly iyo Company) oo ay weheliso daawaynta endocrine (tamoxifen ama aromatase inhibitor) ee daawaynta adjuvant ee bukaanka qaangaarka ah

KEYTRUDA, Merck, Pembrolizumab, Kordhinta TNBC

Pembrolizumab waxaa FDA u ansixisay halista hore ee kansarka naasaha ee saddex-taban leh

Ogosto 2021: Pembrolizumab (Keytruda, Merck) waxaa FDA u ansixisay halis sare, kansarka naasaha ee saddex-geesoodka ah (TNBC) oo ah daaweyn neoadjuvant oo ay weheliso kiimoterabi, iyo markii dambe oo ah wakiil keliya sida adjuv ..